Qure.ai has achieved a significant milestone with the acquisition of a Class III medical device licence from Health Canada for its suite of medical imaging AI solutions. This approval marks a critical step in Qure.ai’s expansion into the Canadian healthcare market, offering advanced AI-powered tools designed to enhance clinical decision-making and patient care.
Qure.ai’s AI solutions are engineered to improve diagnostic accuracy and efficiency, ultimately aiming to enhance patient outcomes through earlier detection and intervention. The Class III licence encompasses all of Qure.ai’s products:
- qXR: An AI tool for chest X-rays that detects a wide range of abnormalities, including lung nodules. It prioritizes abnormal cases for rapid clinical review and reporting.
- qCT: An AI solution for lung nodule management on Chest CT, supporting lung cancer screening programs and tracking nodule growth.
- qER: An AI tool for neurocritical CT scans, aiding in the swift detection of strokes, traumatic brain injuries, and other neurological conditions.
- Endotracheal and Tracheostomy Tube Detection: AI to accurately detect and measure tube tips, identify pneumothorax, and triage critical findings using chest radiography.
- Qure App: Enables clinicians to remotely view and diagnose X-rays, CT, MR, and other scans, streamlining patient care and providing critical alerts for early intervention.
Prashant Warier, Co-founder and CEO of Qure.ai, expressed his enthusiasm, stating, “Receiving the Class III licence from Health Canada is a testament to the rigor and quality of our AI algorithms. This approval allows us to bring our globally proven AI solutions to the Canadian healthcare market, where we can support healthcare professionals in making earlier, more accurate, and efficient diagnoses, placing patient care at the forefront of digital healthcare transformation.”
This Class III medical device licence from Health Canada complements Qure.ai’s existing credentials, including approvals from the USA Food and Drug Administration (FDA) and the European Union Medical Device Regulation (EU MDR) CE mark.